Short Courses and Special Courses

SC10 - Actionable New Trends and Concepts in GU Pathology - An Update for Urinary Bladder, Prostate, and Kidney

Thursday, March 22, 2018 - 8:00 am - 11:30 am
This Short Course session includes up to a half-hour break.

Session Credits:

3 CME and 3 SAMs

Faculty

Gladell P. Paner, MD, University of Chicago, Chicago, IL
Rafael E. Jimenez, MD, Mayo Clinic, Rochester, MN
Steven C. Smith, MD, PhD, VCU School of Medicine, Richmond, VA

Course Description

In an area that has seen a panoply of new variants, recent classification and staging consensuses, and disruptive technological change, this course is designed to be a targeted overview of practical, newer concepts that have developed sufficiently to be ready for implementation in daily practice in these organ systems. The course is intended for surgical pathologists and trainees, even GU specialists interested in a perspective on action items in tumor pathology of the urinary bladder, prostate gland, and kidney.

This short course, guided by multiple case presentations per organ system illustrating practice changers in action, will spend approximately one hour per organ site. In bladder, contemporary understanding regarding the therapeutic implications of pathologic recognition of variant morphologies and new understanding of staging challenges will be emphasized. In prostate, an update regarding changes in grading and reporting will be placed in context of new paradigms arising from new imaging techniques and focal therapy. In kidney, the multiplying spectrum of proposed entities will be distilled into pragmatic differential diagnoses where the pathologist has the ability to add real value in recognition of tumors where maturing data support actionable prognostic, therapeutic, and hereditary differences.

Before the meeting, course registrants will be able to access case presentations through the USCAP website for pre-review, with a syllabus for the course outlining the differential diagnoses and their relationship to the actionable trends emphasized per organ system. Course registrants will also receive access to the presenters’ slides in the post-meeting materials. Finally, post-meeting questions will be made available for self-assessment to count as a Self-Assessment Modules (SAMs) for ABP MOC credit.

Learning Objective

Upon completion of this educational activity, the learner will be able to:

  • Understand and diagnose clinically relevant variants of urothelial carcinoma, while understanding and applying contemporary criteria for staging challenges
  • Employ recent key changes in grading, reporting and quantification in prostate cancer
  • Recognize and differentiate newer variants of renal cell carcinoma with specific prognostic, therapeutic, and hereditary implications.

 

Continuing Medical Education and Maintenance of Certification

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Physicians must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 3 SAM credit hours.

 

Return to 2018 Annual Meeting Short Course Page

Meetings

view more